Skip to content
Open in App
Ascendis Pharma AS logo

Ascendis Pharma AS

web2

Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCo...

Symbol · ASND
Company profile

About

Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is based in Hellerup, Denmark.

Explore by sector

Explore this sector

Market identity

Exchange listings

Listing identities only. Orbitrum does not publish live prices or market performance on this public profile.

People

Company team

JB

Jean-Jacques Bienaime

Non-Executive Director

Company leadership profile.

AC

Albert Cha

Independent Chairman

Company leadership profile.

JM

Jan Moller Mikkelsen

President, CEO, Member of Executive Board & Executive Director

Company leadership profile.

LH

Lars Holtug

Independent Director

Company leadership profile.

LB

Lisa Bright Morrison

Independent Director

Company leadership profile.

SI

Siham Imani

Independent Director

Company leadership profile.

WC

William Carl Fairey

Independent Director

Company leadership profile.

Expert coverage

1 expert evaluated Ascendis Pharma AS.

Orbitrum research

Experts evaluating Ascendis Pharma AS

Explore the public profiles of experts who have evaluated this project.

Orbitrum Academy

Learn how to read a project assessment